BOSTON and TORONTO, June 04, 2021 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group”), an innovative global cannabinoid company, and Ginkgo Bioworks, Inc. (“Ginkgo”), which is building...
Organism engineering
Who Owns CRISPR in 2021? It’s Even More Complicated Than You Think
The question of who owns CRISPR, the genetic editing tool expected to transform modern medicine, is a confusing mess of legal battles, obscure naming conventions, and subtle variations in molecular form and function...
